je.st
news
Amgen: Allowing Dividend Growth Investors To Capitalize On The Biotech Sell-Off
2014-04-01 12:54:12| Biotech - Topix.net
In my opinion, Amgen is the only viable option for a conservative income investor looking for large-cap exposure to biotech.
Tags: growth
allowing
investors
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||